Log In
Print
BCIQ
Print
Print this Print this
 

COG112

  Manage Alerts
Collapse Summary General Information
Company Cognosci Inc.
DescriptionApolipoprotein E mimetic peptide
Molecular Target NF-kappa B (NF-kB)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat Multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today